Several exosite inhibitors abrogated cancer cell migration through specific prevention of the association of pro-MMP-9 with both α4β1 integrin and CD44 without modulating the catalytic activity of MMP-9 [21–23]. The gene discussed is MMP9; the disease is cancer.